RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Leukemia

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2013.324PMID 24186003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

  2013cited by this paper
• M-CSF instructs myeloid lineage fate in single haematopoietic stem cells

  2013cited by this paper
• Fast gapped-read alignment with Bowtie 2

  2012cited by this paper
• ChimeraScan: a tool for identifying chimeric transcription in sequencing data

  2011cited by this paper
• New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases.

  2010cited by this paper
• TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals

  2010cited by this paper
• Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1

  2009cited by this paper
• A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia.

  2007cited by this paper
• Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.

  2005cited by this paper
• dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data

  2004cited by this paper
• Acute lymphoblastic leukemia.

  2004cited by this paper
• Cytogenetics in acute leukemia.

  2004cited by this paper
• Felix Mitelman: Database of chromosome aberrations in cancer

  2002cited by this paper
• Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome‐positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid

  2002cited by this paper
• Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

  2001cited by this paper
• Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

  2001cited by this paper
• Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

  1996cited by this paper
• Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

  1991cited by this paper
• FMS mutations in myelodysplastic, leukemic, and normal subjects.

  1990cited by this paper
• Acute lymphoblastic leukemia.

  1982cited by this paper

• From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents

  2025cites this paper
• G3BP1::CSF1R: a new and actionable gene fusion in acute megakaryoblastic leukemia

  2024cites this paper
• Genetic subtypes of B-cell acute lymphoblastic leukemia in adults.

  2024cites this paper
• RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies

  2024cites this paper
• Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain

  2024cites this paper
• A multiomic characterization of the leukemia cell line REH using short- and long-read sequencing

  2024cites this paper
• A complete digital karyotype of the B-cell leukemia REH cell line resolved by long-read sequencing

  2023cites this paper
• Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).

  2023cites this paper
• Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements

  2023cites this paper
• Whole transcriptome sequencing reveals HOXD11-AGAP3, a novel fusion transcript in the Indian acute leukemia cohort

  2023cites this paper
• Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor acute lymphoblastic leukemia

  2022cites this paper
• Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion

  2022cites this paper
• Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.

  2021cites this paper
• Genetic characterisation of childhood B‐other‐acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation‐dependent Probe Amplification

  2021cites this paper
• Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia

  2021cites this paper
• SFPQ‐ABL1‐positive B‐cell precursor acute lymphoblastic leukemias

  2020cites this paper
• Impaired Condensin Complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL.

  2020cites this paper
• Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics

  2020cites this paper
• CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.

  2019cites this paper
• A comparative proteomic study of plasma in Colombian childhood acute lymphoblastic leukemia

  2019cites this paper
• Transcriptomic data integration for precision medicine in leukemia

  2019cites this paper
• Automated Text Mining and Ranked List Algorithms for Drug Discovery in Acute Myeloid Leukemia

  2019cites this paper
• Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.

  2019cites this paper
• Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion

  2018cites this paper
• The pathogenic role of MEF2D-SS18 fusion gene in B-cell acute lymphoblastic leukemia.

  2018cites this paper
• Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics

  2018cites this paper
• Genetic Screening Test to Detect Translocations in Acute Leukemias by Use of Targeted Locus Amplification.

  2018cites this paper
• MEF2 and the tumorigenic process, hic sunt leones.

  2018cites this paper
• GeneFuse: detection and visualization of target gene fusions from DNA sequencing data

  2018cites this paper
• High-confidence fusion gene detection in different tumor entities & biomarker discovery in breast cancer

  2017cites this paper
• Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles

  2017cites this paper
• The impact of RNA sequence library construction protocols on transcriptomic profiling of leukemia

  2017cites this paper
• New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia.

  2017cites this paper
• High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

  2017cites this paper
• confFuse: High-Confidence Fusion Gene Detection across Tumor Entities

  2017cites this paper
• Philadelphia-Like Acute Lymphoblastic Leukemia in Adults

  2017cites this paper
• BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.

  2017cites this paper
• Receptor Tyrosine Kinases: Translocation Partners in Hematopoietic Disorders.

  2017cites this paper
• Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia

  2016cites this paper
• New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia

  2016cites this paper
• miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression

  2016cites this paper
• MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19

  2016cites this paper
• Method for determining presence/absence of development of malignant lymphoma or leukemia, and drug for treatment and/or prevention of leukemia

  2016cites this paper
• Macrophage colony-stimulating factor receptor marks and regulates a fetal myeloid-primed B-cell progenitor in mice.

  2016cites this paper
• On the origin of B cells. Elucidating the Role of Tyrosine Kinase Receptors in B Cell Development.

  2016influential citation
• A novel recurrent EP300–ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia

  2015cites this paper
• Characterization of Genome Rearrangements from Tumour Sequencing Data

  2015cites this paper
• RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts

  2015cites this paper
• The PDGFR Receptor Family

  2015cites this paper
• Transcriptome Profiling of Pediatric Core Binding Factor AML

  2015cites this paper
• The genome-wide molecular signature of transcription factors in leukemia.

  2014cites this paper
• IKAROS and LEUKEMIA

  2014cites this paper
• Beyond Philadelphia: ‘Ph-like’ B cell precursor acute lymphoblastic leukemias – diagnostic challenges and therapeutic promises

  2014cites this paper
• Toxicogenomics and Cancer Susceptibility: Advances with Next-Generation Sequencing

  2014cites this paper
• Integrated Analysis of Gene Network in Childhood Leukemia from Microarray and Pathway Databases

  2014cites this paper
• Navigating the Rapids: The Development of Regulated Next-Generation Sequencing-Based Clinical Trial Assays and Companion Diagnostics

  2014cites this paper
• Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells

  2014cites this paper